Header
Call for support 1-833-295-8396

For Moderate to Severe Chronic Plaque Psoriasis (PsO)

See why CYLTEZO could help your PsO

CYLTEZO® (adalimumab-adbm) may give you clearer skin.

See Results
View Dosing Information
Woman playing volleyball

Study results: safety and effectiveness

About PsO and CYLTEZO

PsO is the most common type of psoriasis and causes dry, itchy, raised skin patches (plaques) that can appear reddish and scaly. CYLTEZO can help.

If you use CYLTEZO to treat PsO, you should be closely monitored and have regular follow-up visits with your doctor.

CYLTEZO offers patients with PsO the same safety and effectiveness as Humira®.

Two clinical studies with adalimumab showed similar results

Clinical Response at 16 Weeks

Plaque Psoriasis symptoms icon

In two clinical studies, more adults taking adalimumab experienced skin clearance (measured by PGA)* in 16 weeks than those taking placebo.

62% of patients experienced skin clearance icon

In one study, 62% of the patients who took adalimumab experienced skin clearance (measured by PGA)* at 16 weeks compared to 4% of the patients who took placebo.

71% of patients achieved graph and 75% improvement

At 16 weeks, 71% of patients who took adalimumab achieved a 75% improvement in the extent and severity of psoriasis (measured by PASI 75)† compared to 7% in the placebo group. The primary outcome measure was the proportion of patients achieving clinical response at Week 16 relative to the Baseline (Week 0) PASI score.

71% of patients experienced skin clearance icon

In another study, 71% of the patients who took adalimumab experienced skin clearance (measured by PGA)* at 16 weeks compared to 10% of the patients who took placebo.

78% of patients acheived improvements in psoriasis icon

At 16 weeks, 78% of patients who took adalimumab achieved 75% improvement in the extent and severity of psoriasis (measured by PASI 75)† compared to 19% in the placebo group.

The most common side effects of CYLTEZO include injection site reactions, upper respiratory infections (including sinus infections), headaches, and rash. The symptoms of injection site reactions such as redness, rash, swelling, itching, or bruising usually will go away within a few days. Call your doctor right away if you have pain, redness or swelling around the injection site that does not go away within a few days or gets worse.

These are not all the possible side effects with CYLTEZO. Tell your doctor if you have any side effect that bothers you or that does not go away.

View Dosing Information
Woman playing volleyball

Your PsO experience
with CYLTEZO starts
now

Learn About Starting Treatment

*Skin clearance is defined as achieving a clear or minimal score assignment in Physician Global Assessment (PGA) scoring system, which measures treatment response using redness, thickening/hardening, and scaling of skin.

†Psoriasis Area and Severity Index (PASI) 75 response reports percentage of patients who achieved at least 75% reduction in the PASI score. PASI score measures the severity and extent of psoriasis.

What is CYLTEZO?

This important information also applies to Adalimumab-adbm injection for subcutaneous use.

CYLTEZO is a medicine called a tumor necrosis factor (TNF) blocker. CYLTEZO is used:

  • To reduce the signs and symptoms of:
  • moderate to severe rheumatoid arthritis (RA) in adults. CYLTEZO can be used alone, with methotrexate, or with certain other medicines.
  • moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in children 2 years and older. CYLTEZO can be used alone or with methotrexate.
  • psoriatic arthritis (PsA) in adults. CYLTEZO can be used alone or with certain other medicines.
  • ankylosing spondylitis (AS) in adults.
  • moderate to severe hidradenitis suppurativa (HS) in adults.
  • To treat moderate to severe Crohn’s disease (CD) in adults and children 6 years of age and older.
  • To treat moderate to severe ulcerative colitis (UC) in adults. It is not known if adalimumab products are effective in people who stopped responding to or could not tolerate TNF-blocker medicines.
  • To treat moderate to severe chronic (lasting a long time) plaque psoriasis (Ps) in adults who have the condition in many areas of their body and who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light alone or with pills).
  • To treat non-infectious intermediate, posterior, and panuveitis in adults.
Important Safety Information for CYLTEZO® (adalimumab-adbm) injection, for subcutaneous use

This important information also applies to Adalimumab-adbm injection for subcutaneous use.

What is the most important information I should know about CYLTEZO?

You should discuss the potential benefits and risks of CYLTEZO with your doctor. CYLTEZO is a TNF-blocker medicine that can lower the ability of your immune system to fight infections. You should not start taking CYLTEZO if you have any kind of infection unless your doctor says it is okay.

  • Serious infections have happened in people taking adalimumab products. These serious infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some people have died from these infections. Your doctor should test you for TB before starting CYLTEZO and check you closely for signs and symptoms of TB during treatment with CYLTEZO, even if your TB test was negative. If your doctor feels you are at risk, you may be treated with medicine for TB.
  • Cancer. For children and adults taking TNF blockers, including CYLTEZO, the chances of getting lymphoma or other cancers may increase. There have been cases of unusual cancers in children, teenagers, and young adults using TNF blockers. Some people have developed a rare type of cancer called hepatosplenic T-cell lymphoma. This type of cancer often results in death. If using TNF blockers, including CYLTEZO, your chances of getting two types of skin cancer (basal cell and squamous cell) may increase. These types are generally not life-threatening if treated; tell your doctor if you have a bump or open sore that doesn’t heal.

What should I tell my doctor BEFORE starting CYLTEZO?

Tell your doctor about all of your health conditions, including if you:

  • Have an infection, are being treated for infection, or have symptoms of an infection.
  • Get a lot of infections or have infections that keep coming back.
  • Have diabetes.
  • Have TB or have been in close contact with someone with TB, or were born in, lived in, or traveled where there is more risk for getting TB.
  • Live or have lived in an area (such as the Ohio and Mississippi River valleys) where there is an increased risk for getting certain kinds of fungal infections, such as histoplasmosis, coccidioidomycosis, or blastomycosis. These infections may happen or become more severe if you use CYLTEZO. Ask your doctor if you are unsure whether you have lived in an area where these infections are common.
  • Have or have had hepatitis B.
  • Are scheduled for major surgery.
  • Have or have had cancer.
  • Have numbness or tingling or a nervous system disease such as multiple sclerosis or Guillain-Barré syndrome.
  • Have or had heart failure.
  • Have recently received or are scheduled to receive a vaccine. CYLTEZO patients may receive vaccines, except for live vaccines. Children should be brought up to date on all vaccines before starting CYLTEZO.
  • Are allergic to rubber or latex.
  • Are allergic to any CYLTEZO ingredients.
  • Are pregnant, planning to become pregnant, breastfeeding, or planning to breastfeed.
  • Have a baby and you were using CYLTEZO during your pregnancy. Tell your baby’s doctor before your baby receives any vaccines.

Also tell your doctor about all the medicines you take. You should not take CYLTEZO with ORENCIA® (abatacept), KINERET® (anakinra), REMICADE® (infliximab),
ENBREL® (etanercept), CIMZIA® (certolizumab pegol), or SIMPONI® (golimumab). Tell your doctor if you have ever used RITUXAN® (rituximab), IMURAN®
(azathioprine), or PURINETHOL® (mercaptopurine, 6-MP).

What should I watch for AFTER starting CYLTEZO?

CYLTEZO can cause serious side effects, including:

  • Serious infections. These include TB and infections caused by viruses, fungi, or bacteria. Symptoms related to TB include a cough, low-grade fever, weight loss,
    or loss of body fat and muscle.
  • Hepatitis B infection in carriers of the virus. Symptoms include muscle aches, feeling very tired, dark urine, skin or eyes that look yellow, little or no appetite,
    vomiting, clay-colored bowel movements, fever, chills, stomach discomfort, and skin rash.
  • Allergic reactions. Symptoms of a serious allergic reaction include hives; trouble breathing; and swelling of your face, eyes, lips, or mouth.
  • Nervous system problems. Signs and symptoms include numbness or tingling, problems with your vision, weakness in your arms or legs, and dizziness.
  • Blood problems (decreased blood cells that help fight infections or stop bleeding). Symptoms include a fever that does not go away, bruising or bleeding very
    easily, or looking very pale.
  • Heart failure (new or worsening). Symptoms include shortness of breath, swelling of your ankles or feet, and sudden weight gain.
  • Immune reactions, including a lupus-like syndrome. Symptoms include chest discomfort or pain that does not go away, shortness of breath, joint pain, or rash on your cheeks or arms that gets worse in the sun.
  • Liver problems. Symptoms include feeling very tired, skin or eyes that look yellow, poor appetite or vomiting, and pain on the right side of your stomach
    (abdomen). These problems can lead to liver failure and death.
  • Psoriasis (new or worsening). Symptoms include red scaly patches or raised bumps that are filled with pus.

Call your doctor or get medical care right away if you develop any of the above symptoms.

The most common side effects of CYLTEZO include injection site reactions (pain, redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus
infections), headaches, and rash. These are not all the possible side effects with CYLTEZO. Tell your doctor if you have any side effect that bothers you or that does
not go away.

Remember to tell your doctor right away if you have an infection or symptoms of an infection, including:

  • Fever, sweats, or chills
  • Muscle aches
  • Cough
  • Shortness of breath
  • Blood in phlegm
  • Warm, red, or painful skin or sores on your body
  • Diarrhea or stomach pain
  • Burning when you urinate
  • Urinating more often than normal
  • Feeling very tired
  • Weight loss

These are not all the possible side effects of CYLTEZO. For more information, speak with your doctor or pharmacist.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

CL-CTZ-100017 SEPT 2023